Benzinga

Benzinga

Benzinga

miércoles, agosto 19

Zevra Therapeutics Inc

ZVRANASDAQ
Trade with Public
Trade with Public
$12.13
0.564.84%
al cierre: Aug 19, 5:00 PM EST
$12.22
0.090.74%
After hour: 4:14 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Zevra Therapeutics Financials

Zevra Therapeutics (ZVRA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
UPDATE: Zevra Therapeutics Q2 Adj. EPS $0.25 Beats $0.14 Estimate, Sales $39.663M Beat $33.572M Estimate

Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.14 by 78.57 percent. This is a 79.84 percent decrease over earnings of $1.24 per share from
Benzinga Newsdesk

PRO
Zevra Therapeutics Q2 EPS $0.14 Beats $0.11 Estimate, Sales $39.663M Beat $33.881M Estimate

Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.11 by 27.27 percent. This is a 88.71 percent decrease over earnings of $1.24 per share from
Benzinga Newsdesk

PRO
CORRECTION: Zevra Therapeutics Q1 Adj. EPS $0.18 Beats $0.08 Estimate, Sales $36.220M Beat $31.960M Estimate

Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.08 by 125 percent. This is a 400 percent increase over losses of $(0.06) per share from the
Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

Zevra Therapeutics Q4 Earnings Report: What Investors Need to Know

Benzinga Insights

PRO
Zevra Therapeutics Q4 EPS $0.19 Beats $0.05 Estimate, Sales $34.125M Beat $28.051M Estimate

Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.05 by 280 percent. This is a 128.36 percent increase over losses of $(0.67) per share from
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved